Akoya Biosciences - Stock

Akoya Biosciences Equity 2024

Akoya Biosciences Equity

53.77 M USD

Ticker

AKYA

ISIN

US00974H1041

In 2024, Akoya Biosciences's equity was 53.77 M USD, a -8.24% increase from the 58.6 M USD equity in the previous year.

Akoya Biosciences Aktienanalyse

What does Akoya Biosciences do?

Akoya Biosciences is an innovative technology company specializing in the development and commercialization of advanced imaging and analysis technologies in the field of life sciences. The company was founded in 2015 and is headquartered in Menlo Park, California. Akoya Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Akoya Biosciences's Equity

Akoya Biosciences's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Akoya Biosciences's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Akoya Biosciences's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Akoya Biosciences's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Akoya Biosciences’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Akoya Biosciences Stock

What is the equity of Akoya Biosciences this year?

Akoya Biosciences has equity of 53.77 M USD this year.

What was the equity of Akoya Biosciences compared to the previous year?

The equity of Akoya Biosciences has increased/decreased by -8.24% decreased compared to the previous year.

What impact does a high equity have on investors of Akoya Biosciences?

A high equity is advantageous for investors of Akoya Biosciences as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Akoya Biosciences?

A low equity can be a risk for investors of Akoya Biosciences, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Akoya Biosciences affect the company?

An increase in equity of Akoya Biosciences can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Akoya Biosciences affect the company?

A reduction in equity of Akoya Biosciences can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Akoya Biosciences?

Some factors that can affect the equity of Akoya Biosciences include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Akoya Biosciences so important for investors?

The equity of Akoya Biosciences is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Akoya Biosciences take to change the equity?

To change equity, Akoya Biosciences can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Akoya Biosciences pay?

Over the past 12 months, Akoya Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Akoya Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Akoya Biosciences?

The current dividend yield of Akoya Biosciences is .

When does Akoya Biosciences pay dividends?

Akoya Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Akoya Biosciences?

Akoya Biosciences paid dividends every year for the past 0 years.

What is the dividend of Akoya Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Akoya Biosciences located?

Akoya Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Akoya Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Akoya Biosciences from 6/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/18/2024.

When did Akoya Biosciences pay the last dividend?

The last dividend was paid out on 6/18/2024.

What was the dividend of Akoya Biosciences in the year 2023?

In the year 2023, Akoya Biosciences distributed 0 USD as dividends.

In which currency does Akoya Biosciences pay out the dividend?

The dividends of Akoya Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Akoya Biosciences

Our stock analysis for Akoya Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Akoya Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.